Robotic-assisted instruments
LigaSure™ robotic-assisted surgery (RAS) Maryland jaw vessel sealer-divider
<p>The LigaSure™ RAS Maryland jaw vessel sealer-divider pairs with the Hugo™ RAS system as the first robotically driven LigaSure™ instrument.</p>
Features
Unlock more choice in RAS.
See how the LigaSure™ RAS Maryland jaw device pairs with the Hugo™ RAS system to give you confidence in every seal.
Resources
Explore these resources to learn more about the LigaSure™ RAS Maryland jaw vessel sealer-divider — and unlock more choice in robotic surgery.
Related links
Surgeries using this instrument carry some residual risk, even when used by trained physicians. The potential adverse events associated with the use of this device include, but are not limited to; airway obstruction, allergic reaction, arrhythmia, bleeding, burns (including thermal and bowel), carcinogen exposure, cardiac arrest, electric shock, foreign body in patient, infection, nerve damage, perforation (including vessel and organ), thromboembolism, and tissue trauma. Use of this equipment without specific procedure training may result in serious unintended patient injury.
The Hugo™ RAS system was evaluated for its effectiveness and safety of specific procedures as a surgical tool for controlling robotic instruments, but not for clinical outcomes related to cancer or other diseases. The potential adverse events associated with the use of robotically assisted surgical devices include, but are not limited to: arrhythmia, bleeding, blunt trauma, bowel perforation, burns (varying degrees, bowel, thermal), crushing injury, delay of treatment (prolonged procedure), electric shock, foreign body in patient, infection, inflammation, tissue damage/trauma, toxicity, or vessel perforation. Please refer to the Hugo™ RAS system user guide and the Hugo™ RAS system indications document for complete indications, contraindictions and risk information.
† 16 of 16 surgeons surveyed after use agreed. May not be indicative of clinical performance.
‡ Bench tissue and animal model may not be indicative of clinical tissue performance.
§ 15 of 16 surgeons surveyed after use agreed. May not be indicative of clinical performance.
◊ Compared to procedures without a vessel sealer.
¶ Based on internal sales data from FY01–FY27.
- LigaSure™ RAS Maryland instructions for use.
- Based on internal test report RE00476319, LigaSure™ RAS Maryland jaw sealer/divider in actue hemostatis and thermal spread porcine study. Baseed on a porcine model. Table 1. October 19, 2019
- Based on internal test report RE00540481, LigaSure™ RAS Maryland jaw sealer/divider surgeon validation marketing report. Based on porcine model. April 26–May 3, 2024.
- Based on internal test report RE00476260, Marystein bench top tissue study. Table 1. August 15, 2024.
- Based on internal test report RE00476323, LigaSure™ RAS Maryland jaw sealer/divider in chronic hemostatis porcine study. Based on a porcine model.December 9, 2023.
- Based on internal test report RE00476346, LigaSure™ RAS Maryland jaw vessel sealer/divider in a lymphatic burst study. Based on porcine model. Table 1. August 11, 2024.